User: Guest

HUMAN MICROBIOME

Global Market Trajectory & Analytics

MCP12453

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

1623
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

293
Interactions with Platform & by Email

PARTICIPANTS

63
Unique # Participated

VALIDATIONS

28
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

SEP 2020

TABLES

171

PAGES

247

EDITION

8

PRICE

USD $4950


Amid the COVID-19 crisis, the global market for Human Microbiome estimated at US$391 Million in the year 2020, is projected to reach a revised size of US$964.5 Million by 2027, growing at a CAGR of 13.8% over the analysis period 2020-2027.Acute Diarrhea, one of the segments analyzed in the report, is projected to grow at a 14.9% CAGR to reach US$527 Million by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Obesity segment is readjusted to a revised 12.6% CAGR for the next 7-year period. This segment currently accounts for a 4.7% share of the global Human Microbiome market.
The Human Microbiome market in the U.S. is estimated at US$115.6 Million in the year 2020. The country currently accounts for a 29.56% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$167.2 Million in the year 2027 trailing a CAGR of 13.2% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.2% and 11.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10% CAGR while Rest of European market (as defined in the study) will reach US$167.2 Million by the year 2027.
In the global Diabetes segment, USA, Canada, Japan, China and Europe will drive the 13.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$12 Million in the year 2020 will reach a projected size of US$29.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$114.2 Million by the year 2027.We bring years of research experience to this 8th edition of our report. The 247-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
DowDuPont, Inc.; Enterome SA; Merck & Co., Inc.; Metabiomics Corporation; Microbiome Therapeutics, LLC.; Osel, Inc.; Second Genome; Vedanta Biosciences, Inc.; ViThera Pharmaceuticals, Inc.; Yakult Honsha Co., Ltd.
» Application (Therapeutics, Diagnostics) » Disease Indication (Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders, Other Diseases) » Product Type (Probiotics, Prebiotics, Foods, Medical Foods, Drugs, Other Product Types)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Human Microbiome Competitor Market Share Scenario Worldwide (in %): 2018E
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Human Microbiome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027
World Historic Review for Human Microbiome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
World 15-Year Perspective for Human Microbiome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2018 & 2027
World Current & Future Analysis for Acute Diarrhea by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027
World Historic Review for Acute Diarrhea by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
World 15-Year Perspective for Acute Diarrhea by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027
World Historic Review for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
World 15-Year Perspective for Obesity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027
World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Autoimmune Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027
World Historic Review for Autoimmune Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
World 15-Year Perspective for Autoimmune Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027
World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Mental Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027
World Historic Review for Mental Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
World 15-Year Perspective for Mental Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027
World Historic Review for Other Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
World 15-Year Perspective for Other Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027
World Historic Review for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
World 15-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027
World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
World 15-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027
World Historic Review for Probiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
World 15-Year Perspective for Probiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Prebiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027
World Historic Review for Prebiotics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
World 15-Year Perspective for Prebiotics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027
World Historic Review for Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
World 15-Year Perspective for Foods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Medical Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027
World Historic Review for Medical Foods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
World 15-Year Perspective for Medical Foods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027
World Historic Review for Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
World 15-Year Perspective for Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
World Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027
World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2018 & 2027
GEOGRAPHIC MARKET ANALYSIS
United States
Market Facts & Figures
US Human Microbiome Market Share (in %) by Company: 2018 & 2027
USA Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
USA Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
USA 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027
USA Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
USA Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
USA 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027
USA Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
USA Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
USA 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027
Canada
Canada Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Canada Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Canada 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027
Canada Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Canada Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Canada 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027
Canada Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Canada Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Canada 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027
Japan
Japan Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Japan Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Japan 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027
Japan Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Japan Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Japan 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027
Japan Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Japan Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Japan 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027
China
China Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
China Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
China 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027
China Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
China Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
China 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027
China Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
China Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
China 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027
Europe
Market Facts & Figures
European Human Microbiome Market: Competitor Market Share Scenario (in %) for 2018 & 2027
Europe Current & Future Analysis for Human Microbiome by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2018 through 2027
Europe Historic Review for Human Microbiome by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Europe 15-Year Perspective for Human Microbiome by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2018 & 2027
Europe Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Europe Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Europe 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027
Europe Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Europe Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Europe 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027
Europe Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Europe Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Europe 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027
France
France Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
France Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
France 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027
France Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
France Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
France 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027
France Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
France Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
France 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027
Germany
Germany Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Germany Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Germany 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027
Germany Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Germany Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Germany 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027
Germany Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Germany Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Germany 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027
Italy
Italy Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Italy Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Italy 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027
Italy Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Italy Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Italy 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027
Italy Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Italy Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Italy 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027
United Kingdom
UK Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
UK Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
UK 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027
UK Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
UK Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
UK 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027
UK Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
UK Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
UK 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027
Rest of Europe
Rest of Europe Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Rest of Europe Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Rest of Europe 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027
Rest of Europe Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Rest of Europe Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Rest of Europe 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027
Rest of Europe Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Rest of Europe Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Rest of Europe 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027
Asia-Pacific
Asia-Pacific Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Asia-Pacific Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Asia-Pacific 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027
Asia-Pacific Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Asia-Pacific Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Asia-Pacific 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027
Asia-Pacific Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Asia-Pacific Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Asia-Pacific 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027
Rest of World
Rest of World Current & Future Analysis for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Rest of World Historic Review for Human Microbiome by Disease Indication - Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Rest of World 15-Year Perspective for Human Microbiome by Disease Indication - Percentage Breakdown of Value Sales for Acute Diarrhea, Obesity, Diabetes, Autoimmune Disorders, Cancer, Mental Disorders and Other Diseases for the Years 2012, 2018 & 2027
Rest of World Current & Future Analysis for Human Microbiome by Application - Therapeutics and Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Rest of World Historic Review for Human Microbiome by Application - Therapeutics and Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Rest of World 15-Year Perspective for Human Microbiome by Application - Percentage Breakdown of Value Sales for Therapeutics and Diagnostics for the Years 2012, 2018 & 2027
Rest of World Current & Future Analysis for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2018 through 2027
Rest of World Historic Review for Human Microbiome by Product Type - Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2017
Rest of World 15-Year Perspective for Human Microbiome by Product Type - Percentage Breakdown of Value Sales for Probiotics, Prebiotics, Foods, Medical Foods, Drugs and Other Product Types for the Years 2012, 2018 & 2027
Total Companies Profiled : 46

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com